Richard B. Westkaemper

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Pharmaceutical Chemistry, Pharmacology, Organic Chemistry
Google:
"Richard Westkaemper"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vardy E, Sassano MF, Rennekamp AJ, et al. (2015) Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides. Chemistry & Biology. 22: 764-75
Vardy E, Mosier PD, Frankowski KJ, et al. (2013) Chemotype-selective modes of action of κ-opioid receptor agonists. The Journal of Biological Chemistry. 288: 34470-83
Elbegdorj O, Westkaemper RB, Zhang Y. (2013) A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55. Journal of Molecular Graphics & Modelling. 39: 50-60
Wu H, Wacker D, Mileni M, et al. (2012) Structure of the human κ-opioid receptor in complex with JDTic. Nature. 485: 327-32
McGovern DL, Mosier PD, Roth BL, et al. (2010) CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity. Journal of Molecular Graphics & Modelling. 28: 612-25
Shah JR, Mosier PD, Peddi S, et al. (2010) 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites. Bioorganic & Medicinal Chemistry Letters. 20: 935-8
Shah JR, Mosier PD, Roth BL, et al. (2009) Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity. Bioorganic & Medicinal Chemistry. 17: 6496-504
Yan F, Bikbulatov RV, Mocanu V, et al. (2009) Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor. Biochemistry. 48: 6898-908
Li G, Aschenbach LC, Chen J, et al. (2009) Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists. Journal of Medicinal Chemistry. 52: 1416-27
Li G, Aschenbach LC, Chen J, et al. (2009) Corrections to design, synthesis, and biological evaluation of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as μ opioid receptor selective antagonists (Journal of Medicinal Chemistry (2009) 52, (1416) DOI 10.1021/jm801272c) Journal of Medicinal Chemistry. 52: 8057
See more...